John Hendrickson Perrigo restates 2016 results

The company posted a GAAP-based net loss of $4 billion for the year.

bio, biotech, lab, microscope, medicine Israeli startup seeks to replace antibiotics

BiomX is planning future treatments for Crohn's Disease, colitis, and even cancer.

Teva  photo: Reuters Teva share price falls below $30

The Teva share price reached its peak in July 2015, when it was trading at over $70.

Assaf Keret, Yaron Bresky  photo: Gil Arbel RM Global to invest $30m in FutuRx biotech startups

RM Global Israel's Yaron Breski: Anyone not involved in breakthrough companies from the beginning won't have a foothold in the next scientific revolution.

Yaky Yanay Photo: Eyal Yizhar Number of life sciences cos up 50% in a decade

IATI: The trend in Israel is away from medical devices and towards digital medicine.

Teva Photo: Tamar Matsafi Teva to lay off 500 in Hungary - report

Reports in the Hungarian media say that Teva plans to sell or close down one of its Hungarian plants by the end of 2018.

Teva  photo: PR Teva 2017: Acquisitions out, cost-cutting in

Since August, the number of employees at Teva has dropped by 5,000, including 1,700 since the beginning of this year.

Lab Technician.  Photo: Reuters Microbiome therapeutics co BiomX raises $24m

The round was led by OrbiMed, Johnson & Johnson Innovation, and Takeda Ventures.

cancer Intra-body imaging co Body Vision maps lung cancer

Body Vision integrates a CT scan and X-ray in order to remove very small lung tumors that might develop into lung cancer.

Health Photo: Shutterstock ASAP Creative Healthcare meets big data

"Globes" profiles the 10 Israeli startups in the Reboot Forum 2017’s Leading Healthcare Initiative, presenting innovations based mainly on big data analytics.

Twitter Facebook Linkedin RSS Newsletters גלובס Capital  Markets Conference 2017